Updates ·
Health notices · Wednesday 30 September
3 notices from the agencies today, in plain words, each with the original linked.
FDA Class I recall of epinephrine injection vials
FDA · Recall
If you use epinephrine injection from AMERICAN REGENТ, the FDA has issued a Class I recall (highest-risk category). The concern is visible particles in the vial and inadequate assurance the product is sterile.
The notice describes particulate matter identified as nylon, cellulosic, acrylic, polyethylene, and glass, including broken and leaking vials. This was distributed nationwide within the U.S.
If you have these vials, check whether you should stop using them and how to return them. The FDA recall notice is the key source for the exact next steps.
FDA approved ozanimod (ZEPOSIA) for MS and ulcerative colitis
FDA · Approval
The US Food and Drug Administration has approved OZANIMOD (brand name ZEPOSIA) as a sphingosine 1‑phosphate (S1P) receptor modulator. It is for adults with relapsing forms of multiple sclerosis (MS).
ZEPOSIA is also approved for adults with moderately to severely active ulcerative colitis (UC).
What changes for you tomorrow is that this treatment is now an FDA-approved option for these conditions, if prescribed for you.
CDC updated resources for early care and education providers
Centers for Disease Control and Prevention (CDC) · Guidance
If you work in early care and education (ECE), CDC’s Early Care and Education Portal highlights your role in protecting children, supporting healthy development, and helping prevent injuries and disease.
The update includes links to free trainings and tools, such as ones focused on adverse childhood experiences (ACEs), monitoring developmental milestones, and keeping hands and learning spaces clean.
CDC also shares ideas for emotional well-being for staff, and other resources to support families—such as guidance related to healthy habits and vaccination support.
What to do
- Use the Early Care and Education Portal to access CDC’s listed free trainings and resources.